We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SVRA icon
2301
Savara
SVRA
$1.08B
$36.5K ﹤0.01%
9,054
– –
ALT icon
2302
Altimmune
ALT
$560M
$36.4K ﹤0.01%
5,470
– –
MEI icon
2303
Methode Electronics
MEI
$602M
$36.4K ﹤0.01%
3,514
– –
KRUS icon
2304
Kura Sushi USA
KRUS
$637M
$36.3K ﹤0.01%
575
– –
ITOS
2305
DELISTED
iTeos Therapeutics
ITOS
$36.3K ﹤0.01%
2,444
– –
FFEB icon
2306
FT Vest US Equity Buffer ETF February
FFEB
$1.42B
$36.3K ﹤0.01%
775
– –
OABI icon
2307
OmniAb
OABI
$497M
$36.2K ﹤0.01%
9,652
– –
REPL icon
2308
Replimune Group
REPL
$1.43B
$36.2K ﹤0.01%
4,017
– –
NLOP
2309
Net Lease Office Properties
NLOP
$171M
$35.8K ﹤0.01%
+1,455
New +$34.4K
PACB icon
2310
Pacific Biosciences
PACB
$357M
$35.7K ﹤0.01%
26,094
– –
HTB
2311
HomeTrust Bancshares
HTB
$831M
$35.7K ﹤0.01%
1,190
– –
BWMN icon
2312
Bowman Consulting
BWMN
$732M
$35.5K ﹤0.01%
1,118
– –
DENN
2313
DELISTED
Denny's
DENN
$35.5K ﹤0.01%
4,997
– –
HCAT icon
2314
Health Catalyst
HCAT
$132M
$35.4K ﹤0.01%
5,546
– –
WLDN icon
2315
Willdan Group
WLDN
$1.29B
$35.4K ﹤0.01%
1,228
+330
+37% +$9.84K
RGP icon
2316
Resources Connection
RGP
$144M
$35.3K ﹤0.01%
3,200
– –
SHBI icon
2317
Shore Bancshares
SHBI
$801M
$35.3K ﹤0.01%
3,085
– –
TRC icon
2318
Tejon Ranch
TRC
$441M
$35.2K ﹤0.01%
2,066
– –
HOUS
2319
DELISTED
Anywhere Real Estate
HOUS
$35.2K ﹤0.01%
10,639
– –
FUBO icon
2320
FuboTV Inc
FUBO
$293M
$35.2K ﹤0.01%
2,366
– –
CRGX
2321
DELISTED
CARGO Therapeutics
CRGX
$35.2K ﹤0.01%
2,144
– –
DHIL
2322
DELISTED
Diamond Hill
DHIL
$35.2K ﹤0.01%
250
– –
CMP icon
2323
Compass Minerals
CMP
$1.12B
$35.2K ﹤0.01%
3,406
– –
TSHA icon
2324
Taysha Gene Therapies
TSHA
$1.92B
$35.1K ﹤0.01%
+15,672
New +$45.6K
AGS
2325
DELISTED
PlayAGS
AGS
$35.1K ﹤0.01%
3,050
– –
91 92
93
94 95

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.